- Filed
- May 23, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · May 20, 2025 | 51.35M sh |
| Cash And Equivalents | FY 2025 · Mar 31, 2024 | $105.56M |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $184.5M |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $207.03M |
| Current Assets | FY 2025 · Mar 31, 2024 | $302.23M |
| Total Assets | FY 2025 · Mar 31, 2024 | $454.68M |
| Shares Diluted restated | FY 2025 · Mar 31, 2023 | 52.78M sh |
| Stock Repurchased | FY 2025 · Mar 31, 2023 | $93.68M |
| Capex | FY 2025 · Mar 31, 2023 | $26.32M |
| Operating Cash Flow | FY 2025 · Mar 31, 2023 | $82.29M |
| Eps Diluted restated | FY 2025 · Mar 31, 2023 | $1.26 |
| Eps Basic restated | FY 2025 · Mar 31, 2023 | $1.28 |
| Sga Expense | FY 2025 · Mar 31, 2023 | $73.71M |
| Net Income | FY 2025 · Mar 31, 2023 | $66.37M |
| Gross Profit | FY 2025 · Mar 31, 2023 | $158.26M |
| Cost Of Revenue | FY 2025 · Mar 31, 2023 | $560.3M |
| Revenue | FY 2025 · Mar 31, 2023 | $718.56M |
| Stockholders Equity | FY 2025 · Mar 31, 2022 | $212.4M |